[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369235-105":59,"doc-detail-369235-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","feature-selection-and-network-driven-analyses-to-unveil-common-rna-signatures-in-colon-and-pancreatic-kras-mutant-cancers-research-article","Feature Selection and Network-Driven Analyses to Unveil Common RNA Signatures in Colon and Pancreatic KRAS-Mutant Cancers - Research Article","","Colon cancer and pancreatic ductal adenocarcinoma are aggressive malignancies with limited therapeutic options and shared KRAS-related biology, including pathogenic KRAS variants and overlapping epidemiologic patterns. This study integrates multidimensional DNA-Seq and RNA-Seq datasets using machine learning feature selection and bioinformatics network inference to characterize KRAS-missense-linked transcriptional changes common to both cancer types. A prioritized gene set and a top upregulated network were identified, with validation trends assessed by qRT-PCR in representative colon and pancreatic cancer cell lines. Further work is needed to define diagnostic and prognostic value.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/feature-selection-and-network-driven-analyses-to-unveil-common-rna-signatures-in-colon-and-pancreatic-kras-mutant-cancers-research-article/369235/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/feature-selection-and-network-driven-analyses-to-unveil-common-rna-signatures-in-colon-and-pancreatic-kras-mutant-cancers-research-article/369235.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study?","Question",{"text":112,"@type":113},"To uncover transcriptional changes shared between colon and pancreatic cancers that are closely related to KRAS missense mutations, and to reveal potential biomarkers and therapeutic targets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the data and analyses performed?",{"text":117,"@type":113},"The study applied a feature selection technique and Qiagen’s Ingenuity Pathway Analysis to combine DNA-Seq and RNA-Seq data from mutant and wild-type KRAS tumor samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings?",{"text":121,"@type":113},"Feature selection prioritized 70 discriminative genes involved in KRAS signaling and related processes, and Ingenuity Pathway Analysis identified a top-scoring network of 19 upregulated genes common to both tumor types, with concordant qRT-PCR expression trends in cell lines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369235,1790675859,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nFeature Selection and Network-Driven Analyses to Unveil Common RNA Signatures in Colon and Pancreatic KRAS-Mutant Cancers  \nKatia Pane  | Mario Zanfardino  | Anna Maria Grimaldi  | Ilaria Leone | Silvia Nuzzo  | Marco Salvatore | Monica Franzese   \nBioinformatics And Biostatistics Laboratory, IRCCS SYNLAB SDN, Naples, Italy Correspondence: Mario Zanfardino ([mario.zanfardino@synlab.it](mario.zanfardino@synlab.it))  \nReceived: 6 May 2024 | Revised: 12 November 2024 | Accepted: 22 November 2024  \nFunding: This work was partially supported by Ricerca Corrente's grants from the Italian Ministry of Health.  \nKeywords: colon cancer | feature selection | KRAS mutation | network analysis | pancreatic cancer | prognosis  \nABSTRACT  \nBackground: Colon cancer and pancreatic ductal adenocarcinoma are among the most aggressive tumors for which therapeutic options are limited. Both cancers share common features, such as some KRAS pathogenic variants and common epidemiology. The integration of multidimensional datasets by combining machine learning and bioinformatics approaches could provide deeper insights into the intricate KRAS-related networks underlying cancer progression and unveil novel biomarkers and potential therapeutic targets. This study aimed to uncover colon and pancreatic cancers that shared transcriptional changes closely related to KRAS missense mutations.  \nMethods: Feature Selection (FS) technique and Qiagen's Ingenuity Pathway Analysis (IPA) were used to combine DNA-Seq and RNA-Seq data from mutant and wild-type (WT) KRAS colon and pancreatic tumor samples.  \nResults: From the FS, we prioritized 70 genes (54 protein-coding genes and 16 ncRNA-coding genes) that were able to discriminate between WT and mutated KRAS patients. These genes were involved in KRAS signaling and other related processes, such as EMT signaling, glycolysis, apical junction, Wnt/beta-catenin signaling, and IL-2/STAT5 signaling. Using IPA, we identified a top-scoring network of 19 upregulated genes in both tumor types stratified into mutant KRAS and WT KRAS samples. For a set of genes, qRT–PCR performed on colon and pancreatic representative cancer cell lines showed concordant expression trends when comparing colon-dominant KRAS mutants versus WT KRAS and dominant pancreatic KRAS mutants versus WT KRAS, as expected according to in silico analyses.  \nConclusions: Our findings may provide insight into the common transcriptional signatures potentially underlying colon and pancreatic KRAS-mutant cancers. However, further studies are needed to elucidate the diagnostic and prognostic value of targets identified as common features in our study.  \n\n| Abbreviations: anti-EGFR, anti-epidermal growth factor receptor; CGB8, chorionic gonadotropin beta subunit 8; DKK1, Dickkopf-related protein 1; ECM1, extracellular matrix protein 1; ITGA3, integrin subunit alpha 3; MAPK, mitogen-activated protein kinase; MUC1, Mucin 1; PADI1, peptidylarginine deiminase 1; PHLDA1, pleckstrin homology-like domain, family A, member 1; PI3K-AKT, phosphoinositide 3-kinase, protein kinase B; PLEK2, pleckstrin 2; TGFA, transforming growth factor alpha; TGFBI, transforming growth factor beta induced; WNT7A, Wnt family member 7A. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. |\n\nCancer Medicine, 2025; 14:e70468 1 of 12  \n[https://doi.org/10.1002/cam4.70468](https://doi.org/10.1002/cam4.70468)  \n1 | Introduction  \nColorectal cancer (CRC) is the third most common human cancer and the second leading cause of cancer death worldwide [1, 2] . Moreover, pancreatic ductal adenocarcinoma (PDAC) constitutes approximately 85% pancreatic cancer and is one of the most aggressive and lethal cancers [2, 3] . Both c","cbCaikmhMZFp0oj8","https://ap.wps.com/l/cbCaikmhMZFp0oj8","pdf",4026182,12,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To uncover transcriptional changes shared between colon and pancreatic cancers that are closely related to KRAS missense mutations, and to reveal potential biomarkers and therapeutic targets.\"},{\"question\":\"How were the data and analyses performed?\",\"answer\":\"The study applied a feature selection technique and Qiagen’s Ingenuity Pathway Analysis to combine DNA-Seq and RNA-Seq data from mutant and wild-type KRAS tumor samples.\"},{\"question\":\"What were the key findings?\",\"answer\":\"Feature selection prioritized 70 discriminative genes involved in KRAS signaling and related processes, and Ingenuity Pathway Analysis identified a top-scoring network of 19 upregulated genes common to both tumor types, with concordant qRT-PCR expression trends in cell lines.\"}]","Feature Selection and Network-Driven Analyses to Unveil Common RNA Signatures in Colon and Pancreatic KRAS-Mutant Cancers - Research Article | PDF",1790181546,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7d937874c1c3b85bf6641fc13206bc8.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ca314447479209584ec5d2db3bca5de.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c66581c4f4c6f726eb7f7fb121779f2.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26ae311d7c67b0f91a4f0be203223d22.webp",980,1287]